媒體:
188
建立:
2022/11/16
管理者:
系統管理者, TUA秘書處, TUA會計採購組, TUA學術會議組, TUA學術資訊組, 陳佳能
  1. 知識庫
  2. ...
  3. 年會
  4. 2023年會
  5. 摘要
管理者：系統管理者, TUA秘書處, TUA會計採購組, TUA學術會議組, TUA學術資訊組, 陳佳能
  1. 1.
    Podium 01
    1. 1.1
      PD01-1: The diagnostic rule of prostatic urethral angle in diagnosis of bladder neck dysfunction in men with lower urinary tract symptoms and small prostate volume
    2. 1.2
      PD01-2: Low Intensity Extracorporeal Shockwave Targeting at Dorsal Root Ganglion Attenuate Nociceptive Markers and BOLD activity in a Rat Model of Nonbacterial Chronic Prostatitis
    3. 1.3
      PD01-3: Complication Analysis of Transurethral Resection of Prostate Under Different Types of Anesthesia: A Nationwide, Population-based Cohort Study
    4. 1.4
      PD01-4: Normal post void residual urine in healthy adults
    5. 1.5
      PD01-5: The efficacy of behavioral therapy and different dosage of β3-adrenoceptor agonist treatment for male overactive bladder patients, a comparison study
    6. 1.6
      PD01-6: Analyzing the effects of testosterone level on nocturia in prostate cancer patients receiving androgen deprivation therapy
  2. 2.
    Podium 02
    1. 2.1
      PD02-1: Ferroptosis induction and glutathione peroxidase 4 suppression as mechanisms of Evodiamine's inhibition to high grade bladder cancer cell
    2. 2.2
      PD02-2: GDF15/prothymosin α signaling disruption as a potential therapy for muscle wasting in bladder cancer patients treated with cisplatin
    3. 2.3
      PD02-3: Urinary Exfoliated Cells as a Potential Biomarker for Urothelial Carcinoma
    4. 2.4
      PD02-4: The prognostic significance of CEBPD expression in patients with bladder urothelial carcinoma
    5. 2.5
      PD02-5: The farnesoid X receptor agonist GW4064 inhibits migration and invasion through β-catenin and MMP2 downregulation in human bladder cancer
    6. 2.6
      PD02-6: Comparison of the adverse events between 2 different BCG strains in patients receiving intravesical therapy for non-muscle invasive bladder urothelial carcinoma: A single center experience
  3. 3.
    Podium 03
    1. 3.1
      PD03-1: Environmental melamine exposure increases renal tubular injury via oxidative stress in patients with calcium urolithiasis: The possible mechanism of melamine associated urolithiasis formation
    2. 3.2
      PD03-2: Molecular analysis of HK-2 cells exposed to oxalate and calcium oxalate crystals: in vitro model of calcium oxalate nephrolithiasis
    3. 3.3
      PD03-3: Apply machine learning to the interpretation of urinary crystal morphology
    4. 3.4
      PD03-4: Inflammatory cytokines enhance osteogenic proteins expression in renal tubular cells
    5. 3.5
      PD03-5: Glycated Tamm-Horsfall protein of diabetes patients decrease the function on crystal aggregation inhibition
    6. 3.6
      PD03-6: Urinary stone analysis and clinical characteristics of 630 patients in Taiwan
  4. 4.
    Podium 04
    1. 4.1
      PD04-1: Magnetic Resonance Imaging/Ultrasound Fusion-guided Transperineal Magnetic Resonance Imaging/Ultrasound Fusion-guided Transrectal prostate biopsy in the diagnosis of prostate cancer: Experience in National Taiwan University Hospital, a tertiary me
    2. 4.2
      PD04-2: Optimal sequencing treatment in castration resistance prostate cancer—A retrospective study in Kaohsiung Chang Gung Memorial Hospital
    3. 4.3
      PD04-3: The secondary metabolite Lu01-M from the marine streptomyces sp. exhibited cytotoxic activity in prostate cancer cells by inducing cell cycle arrest and DNA damage
    4. 4.4
      PD04-4: The Association of Matrix Metalloproteinase-7 Genotypes with Prostate Cancer Risk in mid-Taiwan
    5. 4.5
      PD04-5: Outcomes between High-intensity focused ultrasound ablation with and without transurethral resection of the prostate in the patients with localized prostate cancer
    6. 4.6
      PD04-6: The Side Effects of Different Vaccinations for Metastatic Prostate Cancer Patients under Systemic Treatment
  5. 5.
    Podium 05
    1. 5.1
      PD05-1: Effectiveness Of Platelet-Rich Plasma Injection In The Prophylaxis Of Recurrent Urinary Tract Infection In Women
    2. 5.2
      PD05-2: Urinary Biomarkers in Differential Diagnosis of Female Urgency Frequency Syndrome
    3. 5.3
      PD05-3: Urethral sphincter electrophysiology study of female dysfunctional voiding and the effect on treatment outcome of urethral Botox injections
    4. 5.4
      PD05-4: Transurethral Bladder Neck Incision for Female Voiding Dysfunction: Analyzing Outcomes, Success Factors, and Repeat Procedure Benefits
    5. 5.5
      PD05-5: Clinical characteristics and underlying pathophysiology in women with mid-urethral dysfunctional voiding
    6. 5.6
      PD05-6: The presentation of two subtypes of primary bladder neck obstruction in female patients. Is it different in severity?
  6. 6.
    Podium 06
    1. 6.1
      PD06-1: Darolutamide in combination with androgen-deprivation therapy and docetaxel in patients with metastatic hormone-sensitive prostate cancer by disease volume and risk in the phase 3 ARASENS trial
    2. 6.2
      PD06-2: Real-world Study on Darolutamide, Enzalutamide, and Apalutamide for Nonmetastatic Castration-Resistant Prostate Cancer Patients Using a Urology Network in the United States (DEAR Study)
    3. 6.3
      PD06-3: Inhibition of LGALS1 Enhances ENZ Sensitivity in AR-Expressing Prostate Cancer Cells by Suppressing Energy Metabolism
    4. 6.4
      PD06-4: Prostate Health Index (PHI) Aids Prostate Cancer Detection in the Grey Zone of MRI- (PI-RADS 3) Lesions
    5. 6.5
      PD06-5: Anastomotic urinary leakage after Retzius-sparing robot-assisted radical prostatectomy.
    6. 6.6
      PD06-6: The association between sarcopenia and postoperative outcomes after robotic assisted radical prostatectomy
  7. 7.
    Podium 07
    1. 7.1
      PD07-1: Laparoscopic endoscopic single site total extraperitoneal inguinal hernia repair: Experience from single center
    2. 7.2
      PD07-2: Comparison of the outcomes of low-pressure and standard-pressure pneumoperitoneum among patients during laparoscopic surgery with Trendelenburg position
    3. 7.3
      PD07-3: The comparison of seminal plasma extracellular vesicles (SPEV) profile in NOA patients with different sperm retrieval outcome
    4. 7.4
      PD07-4: Artificial intelligence interpretation of touch print smear cytology of testicular specimen from patients with azoospermia
    5. 7.5
      PD07-5: Curcumin retrieved reproductive function in male mice with low-carbohydrate-diet-induced metabolic dysfunction
    6. 7.6
      PD07-6: Could a single implant in the corpus cavernosum be sustainable?
  8. 8.
    Podium 08
    1. 8.1
      PD08-1: Cryoablation for Renal Angiomyolipoma: Analysis of Efficacy and Complication
    2. 8.2
      PD08-2: Predictors for the failed result of ureteral reconstruction: A Real-World Retrospective Study
    3. 8.3
      PD08-3: Urinary Microbiota Distribution and its relationship with Hunner Lesion for female patients with Interstitial Cystitis/Bladder Pain Syndrome
    4. 8.4
      PD08-4: Differences in Clinical Characteristics Between Acute Cystitis Symptoms in Women with and without Irrigation Habits After Toilet Use
    5. 8.5
      PD08-5: Linguistic and Clinical Validation of the Chinese Version of the Acute Cystitis Symptom Score (ACSS) Questionnaire in Women with Uncomplicated Acute Cystitis
    6. 8.6
      PD08-6: Urinary incontinence in children under 5 years of age
  9. 9.
    Podium 09
    1. 9.1
      PD09-1: Recruitment of lymphatic endothelial cells by thrombospondin-4 induces lymphangiogenesis in human bladder tumors
    2. 9.2
      PD09-2: Is the native upper urinary tract urothelial carcinoma different between dialysis patients and renal transplant recipients?
    3. 9.3
      PD09-3: The incidence and multiplex nomogram for prediction of metachronous and synchronous upper tract urothelial cancer in patients with non-muscle invasive urinary bladder cancer
    4. 9.4
      PD09-4: Impact of erythropoiesis-stimulating agents on patients with end stage renal disease and early-stage urothelial carcinoma: A real-world study
    5. 9.5
      PD09-5: The Effects of Cyproheptadine in Eliciting Natural Killer cell-mediated Immune Response in Bladder Cancer
    6. 9.6
      PD09-6: Down-regulation of Aquaporins Sensitizes Atezolizumab-induced Cytotoxicity of urothelial carcinoma
  10. 10.
    Moderated Poster 01
    1. 10.1
      (MP1-01) A real-world experience of using Apalutamide in the treatment of metastatic hormone sensitive prostate cancer
    2. 10.2
      (MP1-02) Public Chinese Prostate Cancer Professional Series-3：Updated Treatment for metastatic Castration-Sensitive Prostate Cancer (mCSPC) (translated from NCCN Prostate Cancer Guidelines 2023 V1)
    3. 10.3
      (MP1-03) Public Chinese Prostate Cancer Professional Series-3：Updated Treatment for metastatic Castration-Resistant Prostate Cancer (mCRPC) (translated from NCCN Prostate Cancer Guidelines 2023 V1)
    4. 10.4
      (MP1-04) Public Chinese Prostate Cancer Professional Series-1：Accurate Diagnosis of Prostate Cancer (translated from NCCN Prostate Cancer Guidelines 2023 V1)
    5. 10.5
      (MP1-05) Public Chinese Prostate Cancer Professional Series-3：Updated Treatment for non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) (translated from NCCN Prostate Cancer Guidelines 2023 V1)
    6. 10.6
      (MP1-06) Public Chinese Prostate Cancer Professional Series-2：Updated Treatment for Clinically Localized/Regional Lymph Node Invasion Prostate Cancer (translated from NCCN Prostate Cancer Guidelines 2023 V1)
    7. 10.7
      (MP1-07) The Impact of F18-Fluciclovine Positron Emission Tomography on Prostate Cancer Managements and Outcomes After Changing Managements
    8. 10.8
      (MP1-08) The long-term survival outcome of radical prostatectomy for localized prostate cancer with positive lymph node
    9. 10.9
      (MP1-09) Molecular Expression Differences between Epithelioid and Sporadic Renal Angiomyolipoma: The Role of PTEN Loss and mTOR Pathway Activation
    10. 10.10
      (MP1-10) Progression-Free Survival Following Stereotactic Body Radiotherapy for Bone Oligometastasis in Prostate Cancer and the Effect of Different Doses: A Single-Urologist, Single-Institute Experience
  11. 11.
    Moderated Poster 02
    1. 11.1
      (MP2-01) Comparison of Thulium Laser Enucleation and Conventional transurethral resection among BPH patients: Single center study of functional outcome
    2. 11.2
      (MP2-02) Artificial urinary sphincters in the treatment of post-prostatectomy incontinence: A summary of 22 years of experience from 4 medical institutions
    3. 11.3
      (MP2-03) Deep drop: a common finding in uroflowmetry of healthy children and adolescents
    4. 11.4
      (MP2-04) Age- and gender-specific normal post void residual urine volume in healthy adolescents
    5. 11.5
      (MP2-05) The Predictive Factors of Common Early Complications Following Transurethral Resection of the Prostate
    6. 11.6
      (MP2-06) Bladder capacity and urinary frequency in children
    7. 11.7
      (MP2-07) Clinical Results of Overnight Catheterization in Patients with Neurogenic Bladder
    8. 11.8
      (MP2-08) Comparison of Holding Strength on ligation Clips with Various Suture Types
    9. 11.9
      (MP2-09) Endoureterotomy for Ureteral Stricture: A Retrospective Study of Holmium Versus Thulium Lasers
    10. 11.10
      (MP2-10) SHARED DECISION-MAKING FOR PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA—A REGIONAL TEACHING HOSPITAL EXPERIENCE
  12. 12.
    Moderated Poster 03
    1. 12.1
      (MP3-01) The outcome of neoadjuvant immunotherapy for muscle-invasive urinary bladder urothelial carcinoma: single-center experience
    2. 12.2
      (MP3-02) The Role of Capsaicin in Inhibiting Bladder Tumor Metastasis through the Regulation of Matrix Metalloproteinase-11 Expression
    3. 12.3
      (MP3-03) The study on the effects of Pterostilbene to cell apoptosis of bladder cancer cells
    4. 12.4
      (MP3-04) Survival outcomes of non-muscle invasive bladder urothelial carcinoma patients stratified by the updated EAU risk groups: Asian cohort
    5. 12.5
      (MP3-05) High Incidence of Upgrading between Ureterorenoscopic Biopsy and Final Pathology in Upper Tract Urothelial Carcinoma: A Single Regional Hospital Experience
    6. 12.6
      (MP3-06) Real-world outcome of endoscopic laser ablation for upper urinary tract urothelial carcinoma
    7. 12.7
      (MP3-07) Comparison of Standard Transurethral Resection of Bladder Tumor and Laser En-bloc Resection of Bladder Tumor: A Single-centered Experience from Taipei Municipal Wanfang Hospital
    8. 12.8
      (MP3-08) Study on sesamin inhibiting malignant progression of human bladder tumor
    9. 12.9
      (MP3-09) Clinical Determinants of Extraurinary Tract Recurrence and Survival after Radical Surgery for pT2 Upper Tract Urothelial Carcinoma
    10. 12.10
      (MP3-10) Postoperatively increased splenic volume correlates with an unfavorable prognosis in patients after radical nephroureterectomy to treat upper tract urothelial carcinoma
  13. 13.
    Moderated Poster 04
    1. 13.1
      (MP4-01) Inflammatory cytokines increase matrix vesicles release from renal tubular cells
    2. 13.2
      (MP4-02) A Meta-analysis and Systematic Review of the Correlation between the Outcome of Urolithiasis and High-dose Vitamin D supplementation
    3. 13.3
      (MP4-03) Positive microscopic uric acid crystal in the morning urine indicates renal uric acid stone formation
    4. 13.4
      (MP4-04) Positive microscopic urinary crystals indicate underlying calcium disorder
    5. 13.5
      (MP4-05) Optimizing Outcomes in Retrograde Intrarenal Surgery for Stones: Factors Affecting Postoperative Complications and Stone-Free Rates
    6. 13.6
      (MP4-06) Safety and Efficacy Outcomes of Retrograde Intrarenal Surgery (RIRS) for Renal Stones: A Single-Center Experience
    7. 13.7
      (MP4-07) Complete Intraureteral Stent Placement Reduces Stent-Related Pain in Normotensive Subjects and in Diabetes: Subgroup Analysis of a Prospective Randomized Clinical Trial
    8. 13.8
      (MP4-08) Outcome evaluation of modified autologous fascial sling operation in female patients with stress urinary incontinence
    9. 13.9
      (MP4-09) Application of Artificial Intelligence (Deep Learning Neural Network) for Assistant Diagnosis of Voiding Dysfunction by Using a Vibration Sensor
    10. 13.10
      (MP4-10) Association between overactive bladder symptoms and psychological disturbance: a questionnaire-based analysis in Taiwan
  14. 14.
    Moderated Poster 05
    1. 14.1
      (MP5-01) Study of histone deacetylase inhibitors blocking malignant progression and bone metastasis in human bladder cancer
    2. 14.2
      (MP5-02) The Prognostic Value of Body Mass Index for Muscle Invasive Bladder Cancer with Different Treatment: A Single-Center Retrospective Study
    3. 14.3
      (MP5-03) 以C 型肝炎病毒感染模式研究Nur77與泌尿道發炎之相關性
    4. 14.4
      (MP5-04) Meta-analysis and Systematic Review of the Prevalence of pT1 Non-muscle Invasive Bladder Cancer via Controlling Nutritional Status (CONUT) Score
    5. 14.5
      (MP5-05) The impact of nutrition status and comorbidity on the prognosis of upper urinary tract urothelial carcinoma
    6. 14.6
      (MP5-06) Therapeutic efficacy and safety of retrograde intrarenal surgery without ureteral access sheath
    7. 14.7
      (MP5-07) Simultaneous Management of Renal Cysts and Stones: A Comparison of Percutaneous Nephrolithotomy and Endoscopic Combined Intrarenal Surgery
    8. 14.8
      (MP5-08) The Association of VEGF 2578C>A Polymorphism with Metabolic Syndrome and Erectile Dysfunction
    9. 14.9
      (MP5-09) Semen analysis improved postoperatively after microsurgical varicocelectomy
    10. 14.10
      (MP5-10) Clinical experience with malleable penile implantation for salvaging inflatable implant infection
  15. 15.
    Non-Discussion Poster
    1. 15.1
      NDP01: Young adult with rarely primary synovial sarcoma of kidney: a case report
    2. 15.2
      NDP02: Cases Report: Primary kidney myopericytoma
    3. 15.3
      NPD03: Zinner syndrome complicated with primary adenocarcinoma of seminal vesicle: A case report and literature review
    4. 15.4
      NPD04: Metastatic renal cell carcinoma without primary tumor: Report of two cases
    5. 15.5
      NPD05: Case Report: Posterior reversible encephalopathy syndrome
    6. 15.6
      NPD06: Rosai-Dorfman disease with para-aortic and unilateral retroperitoneal lymphadenopathy in breast cancer: A rare case report and literature review
    7. 15.7
      NPD07: Primary renal neuroendocrine tumor- A rare case report and literature review
    8. 15.8
      NPD08: Repair of ureteral transection with appendix: a case report and literature review
    9. 15.9
      NPD09: Xanthogranulomatous cystitis mimicking bladder tumor: A case report
    10. 15.10
      NPD10: Outcomes after IVC resection without reconstruction and multiple bowel resections in a patient with recurrent retroperitoneal sarcoma after radiation therapy
    11. 15.11
      NPD11: Primary neuroendocrine tumor (NET) of urachus: a case report
    12. 15.12
      NPD12: An Unusual Presentation of a Bladder endosalpingiosis
    13. 15.13
      NPD13: Metastatic renal cell carcinoma with small intestine invasion presenting as bowel obstruction: a case report and literature review
    14. 15.14
      NPD14: Alveolar rhabdomyosarcoma of epididymis with multiple metastases: A case report
    15. 15.15
      NPD15: Concurrent retroperitoneal neurofibroma and malignant peripheral sheath tumor with hydronephrosis in a patient with neurofibromatosis type 1
    16. 15.16
      NPD16: Penis Classic Kaposi Sarcoma in a HIV-negative patient - A Rare Case Report and Literature Review
    17. 15.17
      NPD17: Case Report: Adrenal Schwannoma
    18. 15.18
      NPD18: Primary female periurethral adenocarcinoma: a case report and review of the literature
    19. 15.19
      NPD19: Follicular lymphoma discovered incidentally during laparoscopic inguinal hernia repair: an uncommon case report
    20. 15.20
      NPD20: Rare differential diagnosis of hematuria: A case report and review of paraganglioma
    21. 15.21
      NPD21: A case report: Non-functional bladder paraganglioma with urinary frequency
    22. 15.22
      NPD22: Case report- Spermatic cord liposarcoma
    23. 15.23
      NPD23: Testicular Leukemia: A Case Report
    24. 15.24
      NPD24: A Huge Seminoma of An Undescended Testis Mimicking Teratoma: A Case Report
    25. 15.25
      NPD25: Cytoreductive nephrectomy in patients with newly diagnosed metastasis renal cell carcinoma treated with Nivolumab+Cabozantinib
    26. 15.26
      NPD26: Eosinophilic cystitis presenting as bulging bladder mass: a case report of rare disease
    27. 15.27
      NPD27: A severely invaded renal tumor cause pulmonary embolism – Case report and literature review
    28. 15.28
      NPD28: Retroperitoneal Schwannoma of Adrenal Incidentaloma: A Case report and series review
    29. 15.29
      NPD29: Multiple Primary Malignancies with Rapid Progress in a Young Male Patient with Systemic Lupus Erythematosus: A Case Report
    30. 15.30
      NPD30: The signs of rapid progression of pheochromocytoma: a case report
    31. 15.31
      NPD31: Case Report: A Bladder Preserving Alternative for Locally Advanced Bladder Cancer with Squamous Differentiation
    32. 15.32
      NPD32: A Case of Primary Retroperitoneal Tumor with Rare Pathology – Neuroendocrine tumor
    33. 15.33
      NPD33: Aggressive angiomyxoma mimicking inguinal hernia: a rare case report
    34. 15.34
      NPD34: Prepubertal teratoma, a rare cause of adult testicular tumor: a case report
    35. 15.35
      NPD35: Multiple primary malignancies: synchronous bladder adenocarcinoma and colon adenocarcinoma – a rare case
    36. 15.36
      NPD36: Malignant Mesothelioma of the Tunica Vaginalis Testis: A Case Report
    37. 15.37
      NPD37: A case report: Adrenal collision tumor
    38. 15.38
      NPD38: An unusual cause of hydronephrosis: Ureteral endosalpingiosis.
    39. 15.39
      NPD39: Paraganglioma in Bladder: A Case Report and Literature Review
    40. 15.40
      NPD40: The Application of Adrenal Vein Sampling in Cushing Syndrome with Bilateral Adrenal Tumors: A Case Report
    41. 15.41
      NPD41: Assessment of the safety of simultaneous resection of bladder tumor and benign prostate:A Case series with Review of Literature
    42. 15.42
      NPD42: Rare case report: Adrenal cortical adenoma with myelolipomatous change
    43. 15.43
      NPD43: Leiomyoma of the testis
    44. 15.44
      NPD44: A rare case with cutaneous metastasis of bladder urothelial carcinoma
    45. 15.45
      NPD45: Surgical experience of adrenal lymphangioma: Mimicking adrenal tumor on image
    46. 15.46
      NPD46: Diagnosis and Treatment of Renal Pseudoaneurysm Found After Percutaneous Nephrolithotomy
    47. 15.47
      NPD47: Infiltrating urothelial carcinoma with focal chordoid, glandular and squamous differentiation of the renal pelvis: a rare case report
    48. 15.48
      NPD48: A Rare Case of Giant Prostate Adenocarcinoma with Rectal Invasion but Low Serum PSA Levels
    49. 15.49
      NPD49: mCRPC with pulmonary metastases, low PSA, and elevated CEA, CA-125, CA-199, NSE, and CYFRA 21-1: a case report
    50. 15.50
      NPD50: Case Report- Nephrogenic adenoma at urinary bladder
    51. 15.51
      NPD51: High-risk Kidney Transplantation with Preformed Donor-specific anti-HLA-Cw1 Antibody - a case report
    52. 15.52
      NPD52: False positive B-cell crossmatch after Rituximab administration in an ABO incompatible renal transplant recipient – Differential diagnosis and management
    53. 15.53
      NPD53: Diagnosis of Renal Arteriovenous Malformation by Flexible Ureterorenoscopy: A Case Report
    54. 15.54
      NPD54: Application of Flexible Ureterorenoscopy in Treatment of Parapelvic Cyst
    55. 15.55
      NPD55: Retroperitoneal fibrosis: A disease of multifactorial etiologies
    56. 15.56
      NPD56: A case report: Severe chronic Groin pain after open inguinal hernioplasty
    57. 15.57
      NPD57: Laparoscopic totally extraperitoneal (TEP) inguinal hernia repair in patients with massive ascites
    58. 15.58
      NPD58: Post robotic-assisted laparoscopic radical prostatectomy pulmonary embolism and acute renal failure: Case report and review of the literature
    59. 15.59
      NPD59: Uncovering the Mystery of Renal Malakoplakia: A Lurking Nightmare
    60. 15.60
      NPD60: A rare cause of pyonephrosis: ureteral stenosis with hematogenous rothia infection
    61. 15.61
      NPD61: Carcinoma in situ of the bladder masquerading as bladder hemangioma
    62. 15.62
      NPD62: ZOLADEX® injection related hematoma in prostate cancer patients: cases report
    63. 15.63
      NPD63: Perforation of the sigmoid colon induced huge abscesses in the retroperitoneum: report of a case
    64. 15.64
      NPD64: Nontraumatic Page kidney– A case report and literature review
    65. 15.65
      NPD65: Case Report: Robotics Renal Cyst Unroofing In External Compression of Parapelvic Cyst
    66. 15.66
      NPD66: A new self-expanding, large-caliber ureteral stent applied for bilateral long segment ureteral stricture
    67. 15.67
      NPD67: Calcium oxalate partial staghorn stone with pyogenic spondylodiscitis – A Case Report
    68. 15.68
      NPD68: A case report of urogenital tuberculosis with associated respiratory failure
    69. 15.69
      NPD69: Intratesticular Hematoma in a Patient with Reiter’s Syndrome: An Unusual Side Effect of Sulfasalazine
    70. 15.70
      NPD70: A Rare Case of Concurrent Bilateral Ureteritis, Cystitis, and Cholangiopathy Associated with Chronic Ketamine Abuse
    71. 15.71
      NPD71: Renal arteriovenous malformation: a rare and potentially life-threatening cause of hematuria
    72. 15.72
      NPD72: Retrocaval ureter, a rare congenital anomaly -- case report
    73. 15.73
      NPD73: Skene’s Duct Cyst: An Uncommon Cause of Female Bladder Outlet Obstruction
    74. 15.74
      NPD74: A case report: Polypoid Cystitis Masquerading Bladder Tumor
    75. 15.75
      NPD75: Percutaneous drainage for management of emphysematous pyelonephritis
    76. 15.76
      NPD76: Vesicovaginal fistula: A Case Report
    77. 15.77
      NPD77: Left ureteral stone and left renal stone in patient with cloacal malformation: a rare case report
    78. 15.78
      NPD78: The 'Popcorn in the Bladder': cystitis cystica et glandularis
    79. 15.79
      NPD79: Large bladder stones with concurrent urethral steinstrasse: A rare case report
    80. 15.80
      NPD80: Testicular Abscess - An Extrapulmonary Manifestation of Tuberculosis
    81. 15.81
      NPD81: Spontaneous renal pelvis rupture caused by distal ureteral stone
    82. 15.82
      NPD82: Non-negligible complication during transurethral resection of the prostate, hyperchloremic metabolic acidosis: a case report and review of literature
    83. 15.83
      NPD83: Pediatric spina bifida combined with neurogenic bladder: A case report
    84. 15.84
      NPD84: Retrograde intrarenal surgery for a complete renal staghorn stone: a case report
地址：台北市 11051 信義區基隆路一段432號6樓之1, 電話：02-2729-0819, 傳真：02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw